Faith L. Charles - 16 Apr 2025 Form 4 Insider Report for CONDUIT PHARMACEUTICALS INC. (CDT)

Role: Director
Signature: /s/ Faith L. Charles
Issuer symbol: CDT
Transactions as of: 16 Apr 2025
Net transactions value: +$100,000
Form type: 4
Filing time: 17 Apr 2025, 16:05:08 UTC
Previous filing: 01 Apr 2025
Next filing: 10 Jul 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CDT	Common Stock	Award	$100,000	+115,194	+230%	$0.8681	165,238	16 Apr 2025	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Faith L. Charles is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Remarks:

Effective as of April 16, 2025, Faith Charles (the "Reporting Person") resigned from her position as a member of the Board of Directors of Conduit Pharmaceuticals Inc (the "Issuer"). As a result, the Reporting Person is no longer subject to Section 16 in connection with her transactions in equity securities of the Issuer and therefore will no longer report any such transactions on Form 4 or Form 5.